Over 30,000 Prescription Cholesterol Drugs Recalled, FDA Says

The two separate recall notices issued by the FDA, affected two types of cholesterol prescription medications.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023.Madalina Vasiliu/The Epoch Times

More than 30,000 prescribed cholesterol drugs were recalled across the United States due to potency and dissolution issues, according to two separate recall notices published late last month by the Food and Drug Administration.

New Jersey-based Zydus Pharmaceuticals recalled 22,896 bottles of icosapent ethyl capsules in 120-count bottles in 1-gram doses, the FDA said in a notice. The recall was classified as Class II by the FDA on Jan. 22, it said.